CLINICAL_TRIALS
withdrawal
· 2017-11-29
Clinical Trial Update: NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock [Phase 4]
Summary
A Phase 4 trial comparing norepinephrine alone versus norepinephrine plus vasopressin for septic shock was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arkansas | Conditions: Shock, Septic | Phase 4 | Status: WITHDRAWN